NCT06369077View on ClinicalTrials.gov

How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?

PHASE4TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Glaucoma, Open-AngleGlaucoma; Drugs
Interventions
DRUG

dorzolamide/timolol

Compare half-frequency dosing of latanoprost and dorzolamide/timolol to full dosing. Compare also to timolol/brimonidine/dorzolamide/bimatoprost

Trial Locations (1)

06851

CT Glaucoma Associates, Norwalk

Sponsors
All Listed Sponsors
lead

CT Glaucoma Associates

OTHER

NCT06369077 - How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? | Biotech Hunter | Biotech Hunter